Statement of Principles concerning melioidosis (Balance of Probabilities) (No. 56 of 2023)

Administered by Department of Veterans' Affairs

Legislation au F2023L00489 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

MELIOIDOSIS

(BALANCE OF PROBABILITIES) (NO. 56 OF 2023)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning melioidosis (Balance of Probabilities) (No. 56 of 2023).

Background

2.             The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 61 of 2014 (Federal Register of Legislation No. F2014L00934) determined under subsection 196B(3) of the VEA concerning melioidosis.

3.             The Authority is of the view that on the sound medical-scientific evidence available it is more probable than not that melioidosis and death from melioidosis can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(3) of the VEA a Statement of Principles concerning melioidosis (Balance of Probabilities) (No. 56 of 2023).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the following kinds of service rendered by a person:

 eligible war service (other than operational service) under the VEA;

 defence service (other than hazardous service and British nuclear test defence service) under the VEA;

 peacetime service under the MRCA,

before it can be said that, on the balance of probabilities, melioidosis or death from melioidosis is connected with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 2 November 2021 concerning melioidosis in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

7.             The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'melioidosis' in subsection 7(2);
  • including ICD-10-AM codes for 'melioidosis' in subsection 7(3);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);
  • revising the factor in subsection 9(1) concerning being exposed to Burkholderia pseudomallei, by the inclusion of a note;
  • revising the factor in subsection 9(2) concerning being in an immunocompromised state, by the inclusion of a note;
  • revising the factor in subsection 9(3) concerning having a medical condition from the specified list of medical conditions;
  • revising the factor in subsection 9(4) concerning for males, having consumed at least 44 kilograms of alcohol within the 3 years before the clinical onset, by the inclusion of a note;
  • revising the factor in subsection 9(5) concerning for females, having consumed at least 30 kilograms of alcohol within the 3 years before the clinical onset, by the inclusion of a note;
  • Deleting the factor concerning being in an immunocompromised state before the clinical worsening;
  • Deleting the factor concerning having a specified condition before the clinical worsening;
  • Deleting the factor concerning for males consuming alcohol before the clinical worsening;
  • Deleting the factor concerning for females consuming alcohol before the clinical worsening;
  • new factor in subsection 9(6) concerning having alcohol use disorder;
  • new definitions of albuminuria, chronic kidney disease, direct contact, ,   in Schedule 1 - Dictionary;
  • revising the definitions of being exposed to Burkholderia pseudomallei, immunocompromised state as specified, immunosuppressive drug,               in Schedule 1 - Dictionary; and

 

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to melioidosis in the Government Notices Gazette of 2 NOVEMBER 2021, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

9.             On 21 December 2022, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instrument and the medical-scientific material considered by the Authority.  This letter emphasised the proposed deletion of factors relating to: being in an immunosuppressed state as specified at the time of the clinical worsening of melioidosis; having a specified condition at the time of the clinical worsening of melioidosis; for males, consuming at least 65 kilograms of alcohol within the three years before the clinical worsening of melioidosis; for females, consuming at least 44 kilograms of alcohol within the three years before the clinical worsening of melioidosis;  The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination.  No submissions were received for consideration by the Authority.  No changes were made to the proposed Instrument following this consultation process.

Human Rights

10.         This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

11.         The determining of this Instrument finalises the investigation in relation to melioidosis as advertised in the Government Notices Gazette of 2 NOVEMBER 2021.

References

12.         A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 56 of 2023

Kind of Injury, Disease or Death: Melioidosis

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(3) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have melioidosis;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, melioidosis is connected with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 61 of 2014; and
  • reflects developments in the available sound medical-scientific evidence concerning melioidosis which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning Melioidosis (Balance of Probabilities) (No. 56 of 2023) is a legislative instrument enacted under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This instrument was introduced to address the gap in the recognition of the relationship between melioidosis and certain types of military service, particularly in light of the evolving medical-scientific evidence regarding the disease. The Repatriation Medical Authority (the Authority) determined this Statement of Principles following an investigation initiated in 2021, which examined the latest medical-scientific evidence available. The Authority concluded that it is more probable than not that melioidosis and death from melioidosis can be related to particular kinds of service, leading to the formulation of this Statement of Principles which replaces the previously repealed Instrument No. 61 of 2014. This new instrument outlines the factors that must exist for a claim to be considered valid under the Acts, facilitating the assessment and review processes for claimants and ensuring that the qualifying conditions for benefits are reasonable, proportionate, and transparent.

Scope and Application

The Statement of Principles concerning melioidosis (Balance of Probabilities) (No. 56 of 2023) applies to persons making claims under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. It sets out the factors that must exist and be related to specific kinds of service in order to establish a connection between melioidosis or death from melioidosis and the service circumstances. This includes eligible war service, defence service, and peacetime service. The Instrument is applicable throughout Australia, as it is determined under the Commonwealth legislative framework. The Statement of Principles reflects the latest available medical-scientific evidence and replaces the previously repealed Instrument No. 61 of 2014. Subordinate instruments may extend or further specify the application of this Statement of Principles, although none are mentioned in this Explanatory Statement. The legislation does not specify any exclusions, exemptions, or thresholds, focusing instead on the balance of probabilities in determining claims related to melioidosis.

Key Provisions

The Statement of Principles concerning melioidosis (Balance of Probabilities) (No. 56 of 2023) (the Statement of Principles) outlines the circumstances in which melioidosis or death from melioidosis can be considered connected with particular kinds of service under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the service, for it to be said that, on the balance of probabilities, melioidosis or death from melioidosis is connected with the circumstances of that service (section 5). This instrument replaces the previously repealed Instrument No. 61 of 2014 and incorporates the latest revisions and updates to the available medical-scientific evidence concerning melioidosis. The Statement of Principles imposes obligations on claimants to provide evidence that the factors outlined in the Statement of Principles are met, and on the Repatriation Commission and the Military Rehabilitation and Compensation Commission to assess such claims based on the evidence provided and the criteria set out in the Statement of Principles. It also facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal. The obligations extend to ensuring that the qualifying conditions for benefits are reasonable, proportionate, and transparent, and that the rights of veterans, current and former Defence Force members, and their dependents are not subject to discrimination. There are no specific offences, penalties, or civil/criminal consequences outlined in the Statement of Principles for breach of its provisions. However, failure to comply with the obligations and requirements of the Statement of Principles may result in the denial of a claim for benefits or compensation. The Statement of Principles is compatible with the human rights and freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011, and it promotes the human rights of veterans, current and former Defence Force members, and their dependents, including the right to social security, the right to an adequate standard of living, and the right to the enjoyment of the highest attainable standard of physical and mental health. The Statement of Principles is a technical instrument that improves the medico-scientific quality of outcomes under the VEA and the MRCA by setting out the circumstances in which melioidosis or death from melioidosis can be considered connected with particular kinds of service. It reflects developments in the available sound medical-scientific evidence concerning melioidosis since the previous instrument was determined. The instrument facilitates the assessment and determination of social security benefits and compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Explanatory Statement
Concepts
Definitions & Interpretation
Regulatory Standards
Consultation Requirements

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.